Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1992-07-20
1994-07-05
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
548228, 558169, 562 11, 562565, 544408, A61K 31675
Patent
active
053267567
ABSTRACT:
The present invention is directed to a new class of beta-ketone, beta oxime and beta hydrazine phosphonate NMDA antagonists.
REFERENCES:
patent: 4746653 (1988-05-01), Hutchinson et al.
patent: 4761405 (1988-08-01), Rzeszotarski et al.
patent: 4906621 (1990-03-01), Hutchinson et al.
patent: 5049555 (1991-09-01), Rzeszotarski et al.
patent: 5095009 (1992-03-01), Whitten et al.
patent: 5217963 (1993-06-01), Hutchison et al.
Pike et al. Biochimica & Biophysica Acta vol. 708 pp. 203-209 (1982).
Wedler et al. Arch. Biochem. Biophys. vol. 202 pp. 422-490 (1980).
Whitten et al. J. Med. Chem. vol. 33 pp. 2961-2963 (1990).
Kehne et al. Chem. Abstr. vol. 114 Entry 199543e (1991).
Kehne et al. Eur. Jour. Pharmacol. vol. 193 pp. 283-292 (1991).
Annual Reports in Medicinal Chemistry, vol. 22, Excitatory Amino Acids and Mammalian CNS Function, Lehmann, et al.; pp. 31-40. (1981).
Annual Reports in Medicinal Chemistry, vol. 24, Recent Advances in Excitatory Amino Acid Research, Graham Johnson, pp. 41-50. (1989).
Annual Reports in Medicinal Chemistry, vol. 26, Recent Advances in Excitatory Amino Acid Research, Johnson, et al.; pp. 11-22. (1991).
An Aspartyl Adenylate Analogue as Effective Inhibitor of Asparagine Synthetase, Zhukov Yu. N., et al; Institute of Molecular Biology, Academy of Sciences of the USSR, Moscow, vol. 14 No. 7 pp. 969-972 (1988).
Baron Bruce M.
Whitten Jeffrey P.
Daus Donald G.
Dixon J. Michael
Merrell Dow Pharmaceuticals Inc.
LandOfFree
R-4-oxo-5 phosphononorvaline used as NMDA antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with R-4-oxo-5 phosphononorvaline used as NMDA antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and R-4-oxo-5 phosphononorvaline used as NMDA antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-796054